
    
      Patients scheduled for mastecotmy with or without axillary dissection, will be randomized to
      receive preoperative either an ultrasound-guided double space paravertebral block or a PECSII
      + parasternal block. In both groups, blocks will be performed with 20 ml of ropivacaine
      0.75%, plus ropivacaine 0.375% 10 ml for parasternal block only.

      All the patients also received a general anesthesia induced by propofol and esmeron for
      endotracheal intubation and desflurane for maintaining.

      Sensory block by ice and pinprick test application and maximum spread after 40' from LA
      injection will be registered.

      Postoperative, all patients will receive a morphine PCA, ketorolac 30 mg/12h and paracetamol
      1g each 8h.

      Morphine consumption will be registered. Patients will follow at 6, 12, 24 months for
      persistent postoperative surgical pain (PPSP) and cancer recurrence.
    
  